AI: DeepSeek (deepseek-chat)

Q: {
  "prompt": "Chunk 11/34",
  "transcriptLength": 2244,
  "transcriptPreview": "### **Medical Clerking â€“ SBAR Format**  \n\n#### **SITUATION:**  \n**Patient:** 58F, PMHx of hypothyroidism (on levothyroxine 50mcg OD), presents to gynaecology clinic with a 6-month history of worsening vulval pruritus and discomfort. Reports dyspareunia and visible white, atrophic patches on vulva. No urinary symptoms.  \n\n#### **BACKGROUND:**  \n- **PMHx:** Hypothyroidism, well-controlled. No DM, no autoimmune conditions.  \n- **ObGyn Hx:** G2P2, menopause at 51, no HRT. No previous vulval patholog...",
  "chunkGuidelines": [
    "clinical-consensus-no-455-fetal-sex-determination-and-disclosure-pdf: Fetal Sex Determination and Disclosure",
    "consultant-midwife-sop-pdf: Consultant Midwife SOP",
    "eclampsia-prompt-card-ed-rsch-prh-pdf: Eclampsia prompt card ED RSCH PRH",
    "eshre-guideline-2022-endometriosis-pdf: ESHRE Guideline: Endometriosis",
    "eshre-guideline-endometriosi-2022-pdf: Guideline on Diagnosis and Management of Endometriosis",
    "eshre-pcos-2023-pdf: International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome",
    "eshre-pil-endometriosis-pdf: Endometriosis: Diagnosis and Management",
    "eshre-rpl-guideline27112017finalv2-pdf: Recurrent Pregnancy Loss Guideline"
  ],
  "chunkIndex": 11,
  "totalChunks": 34
}

A: {
  "success": true,
  "aiResponse": "```json\n{\n  \"mostRelevant\": [],\n  \"potentiallyRelevant\": [\n    {\"id\": \"eshre-guideline-2022-endometriosis-pdf\", \"title\": \"ESHRE Guideline: Endometriosis\", \"relevance\": \"0.3\"},\n    {\"id\": \"eshre-guideline-endometriosi-2022-pdf\", \"title\": \"Guideline on Diagnosis and Management of Endometriosis\", \"relevance\": \"0.3\"}\n  ],\n  \"lessRelevant\": [\n    {\"id\": \"eshre-pil-endometriosis-pdf\", \"title\": \"Endometriosis: Diagnosis and Management\", \"relevance\": \"0.2\"},\n    {\"id\": \"eshre-pcos-2023-pdf\", \"title\": \"International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome\", \"relevance\": \"0.1\"}\n  ],\n  \"notRelevant\": [\n    {\"id\": \"clinical-consensus-no-455-fetal-sex-determination-and-disclosure-pdf\", \"title\": \"Fetal Sex Determination and Disclosure\", \"relevance\": \"0.0\"},\n    {\"id\": \"consultant-midwife-sop-pdf\", \"title\": \"Consultant Midwife SOP\", \"relevance\": \"0.0\"},\n    {\"id\": \"eclampsia-prompt-card-ed-rsch-prh-pdf\", \"title\": \"Eclampsia prompt card ED RSCH PRH\", \"relevance\": \"0.0\"},\n    {\"id\": \"eshre-rpl-guideline27112017finalv2-pdf\", \"title\": \"Recurrent Pregnancy Loss Guideline\", \"relevance\": \"0.0\"}\n  ]\n}\n```",
  "responseType": "string",
  "responseLength": 1147
}